Why BGPT?
logo

Assess an author's data and outputs

See the raw experimental evidence behind an author's publications and reproducibility signals.







Press Enter ↵ to solve



    Fuel Your Discoveries




     Quick Explanation


    Qi Sun scientific-strength review (evidence-limited)
    I cannot confidently attribute the included papers to a specific “Qi Sun” because the provided bibliographic material contains ambiguous name matches (multiple “Qi Sun” authors) and one OpenAlex “top author” entry appears to be unrelated to your target person.
    Within the provided set of papers, the strongest evidence cluster is mechanistic wet-lab work with multi-omics/structural or genetic validation (e.g., NRF2–macrophage resistance in ESCC and RBM15B–H3K79me2→TWINS-region m6A→oncogene translation in MLL-r leukemia ).
    The included computational papers also show methodological sophistication (e.g., context-specific eQTL discovery via SURGE ).
    However, because attribution to the named individual is not established from the provided materials, author-level claims remain uncertain.



     Long Explanation


    Author Review: Qi Sun — scientific strength (skeptical, evidence-bounded)
    Last update reference date: April 20, 2026.
    Critical attribution check (blocking issue)
    Known/uncertain: You asked for a review of “Qi Sun”, but the provided OpenAlex snippet shows multiple distinct authors with similar names (“Qi Sun” appears more than once, with different ORCIDs), and the included “top_author” entry appears to be a different person altogether.

    Consequence: I can evaluate the scientific strength of the provided papers’ methods and evidence, but I cannot reliably claim that these papers are authored by your target “Qi Sun” without a definitive mapping (e.g., a single ORCID or author-ID that matches these DOIs).

    Therefore, the scores below reflect: (i) quality signals inside the provided paper set, and (ii) the uncertainty about author attribution.
    Visual evidence dashboard (from the provided paper list)
    The plot below summarizes the provided per-paper quality scores (scientific quality / novelty / usefulness / generality / reproducibility) from your dataset. Because these scores were included in the prompt rather than derived from primary benchmarks, treat them as descriptive signals, not as an audited bibliometric metric.
    Mechanistic wet-lab & multi-omics evidence (strongest paper-set signals)
    1) NRF2–chemoradiotherapy resistance via immunosuppressive macrophage axis (ESCC)
    The provided description indicates: patient discovery/validation cohorts with WES/WGS + bulk RNA-seq, and mechanistic cell-type/microenvironment support using scRNA-seq and spatial transcriptomics, with correlative ligand–receptor signaling analyses and multiplex validation.
    Where evidence is strong: multi-technology convergence (genome→expression→cell-state→spatial co-localization) plus a biomarker-like genomic alteration pattern (NFE2L2/KEAP1).
    Key vulnerabilities / unknowns: the prompt explicitly notes limited functional perturbation (i.e., causal certainty about macrophage recruitment and whether NRF2 is fully sufficient across contexts), finite per-modality sample sizes, and the need for independent validation.
    2) RBM15B as a chromatin-reader that drives selective m6A and oncogene translation (MLL-r leukemia)
    The provided summary indicates a chain of evidence from chromatin mark recognition (H3K79me2) to recruitment of METTL3 at TWINS-region m6A sites, leading to increased oncogene translation, plus knockdown/perturbation effects and in vivo xenograft/PDX-style setups.
    Where evidence is strong: claims are mechanistically layered (binding/mapping→modification→translation→phenotype), not just correlative expression associations.
    Known uncertainty: context specificity to MLL-r leukemia is highlighted; off-target effects and the scope of generalization remain open.
    3) Ultrastructural mechanism + biochemical activity logic (MEK1/ERK1 phosphorylation interfaces)
    The provided information describes cryo-EM structures of phosphorylated MEK1–ERK1 complexes and a proposed phosphate-transfer catalytic cycle anchored in interface geometry.
    Where evidence is strong: structural data (with deposited PDB/EMDB IDs in the prompt) combined with biochemical assays (e.g., ITC/ATPase/kinase assays) reduce the chance of purely narrative mechanistic claims.
    Blind spot: the prompt notes that the system is in vitro and may not fully recapitulate cellular context; extrapolation to broader MAPK family members needs caution.
    Computational / modeling evidence (strong methodological signals, but causal generalization is harder)
    SURGE: context-specific eQTL discovery via latent-factor modeling
    The prompt indicates an unsupervised probabilistic matrix factorization model that learns latent contexts that modulate eQTL effects; it uses permutation-based empirical FDR calibration and benchmarks via colocalization enrichment on GTEx bulk and PBMC single-cell pseudocells.
    Where evidence is strong: the evaluation strategy explicitly targets disease-relevant colocalizations and uses calibrated FDR to control false positives.
    Key vulnerability: interpretability and power limitations are explicitly noted in the prompt, and interpretive caution is required when latent factors do not align cleanly to measured covariates.
    Synora: boundary-aware spatial omics metric from coordinates + coarse labels
    The prompt says Synora derives oriented, boundary-centric features (boundary × orientedness) from 2D coordinates and coarse tumor/non-tumor labels, applied across Visium HD spatial transcriptomics and CODEX proteomics, with robustness checks including infiltration/missingness/irregular boundary perturbations.
    Strength: explicit robustness testing against perturbations and an emphasis on tissue-architecture features beyond heterogeneity.
    Blind spot: the prompt acknowledges limitations: coarse binary annotations, 2D-only analysis, and lack of orthogonal ground-truth boundary measurements or direct experimental boundary validation.
    Author-level scientific strength inference (with uncertainty)
    What can be inferred from the provided set:
    • Strong mechanistic comfort: at least some included papers show multi-step evidence chains (binding→mapping→functional readouts) and/or high-resolution structural plus biochemical corroboration (examples above).
    • Quantitative rigor signals: the computational papers include explicit robustness/calibration/evaluation designs (SURGE permutation-calibrated FDR; Synora perturbation testing).
    What cannot be concluded: because the materials do not uniquely map the provided DOIs to one “Qi Sun” author, I cannot responsibly claim a reliable author track record, publication quality profile, or expertise domain for the specific individual.
    Useful next BGPT actions (for a proper author disambiguation + deeper critique)


    Feedback:    

    Updated: April 20, 2026

     BGPT Author Review


    Scientific Quality

    50%

    Because the provided materials do not unambiguously attribute the cited papers to the specific individual “Qi Sun,” I cannot credit track record or domain expertise to that person. Within the provided paper set, several studies show strong mechanistic or methodological designs (multi-omics convergence, structural+biochemical evidence, and calibrated statistical modeling), but author-level rigor/consistency cannot be validated from the evidence given. Bias risks include misattribution, over-reliance on prompt-derived summaries, and limited ability to assess replication/independent confirmation at the author level.


    Communication Quality

    60%

    The prompt contains relatively clear one-sentence summaries and structured method/result fields for many papers, which suggests the author(s) communicate complex work in an organized way. However, without access to the actual “Qi Sun” writing/text, I cannot evaluate clarity, framing, or didactic quality directly for the target individual.


    Author Novelty

    60%

    Several provided papers appear methodologically or mechanistically novel (e.g., oriented boundary metrics, latent-context eQTL discovery, chromatin-mark reader→selective m6A→translation axis). Yet, due to attribution uncertainty, novelty can’t be credited to the target person; it only reflects the novelty of the included paper set.


    Scientific Rigor

    60%

    Rigor signals exist in the provided set: multi-modality validation, explicit robustness checks, permutation-based calibration, and structural+biochemical corroboration. But I cannot confirm the target author’s direct role or execution rigor across the set, so the score is moderated by missing author-to-DOI mapping.

     Top Data Sources ExportMCP


     Analysis Wizard



    It will cross-tabulate the provided paper list by DOI, extract each study’s dataset sizes and key model/validation steps, and generate publication-figure-ready score plots to prioritize which analyses to audit first.



     Hypothesis Graveyard


    Strongman: “All therapy resistance can be explained by a single signaling pathway (NRF2) plus a fixed macrophage subset.” This is unlikely because multiple resistance mechanisms and varying microenvironments are common; falsification would occur if other pathways dominate across cohorts or if NRF2 activation fails to predict/drive macrophage engagement in independent settings.


    Strongman: “Latent contexts in SURGE always map cleanly to cell types and always improve interpretability.” This is contradicted by the prompt’s noted interpretability difficulties for some latent contexts; falsification would involve showing that the discovered contexts are unstable across datasets or do not yield robust biological meaning.

     Science Art


    Author Review: Qi Sun Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion








    Get Ahead With Science Insights

    Custom summaries of the latest cutting edge Science research. Every Friday. No Ads.


    My BGPT






     Trending